IMPL logo

Impel Pharmaceuticals (IMPL) EBITDA

Annual EBITDA

-$83.18 M
-$12.79 M-18.16%

December 31, 2022

Summary

Performance

1-Year Change

-18.16%

3-Year Change

-103.66%

5-Year Change

-103.66%

15-Year Change

-103.66%

IMPL EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$40.84 M

3-Year Low

-$83.18 M
IMPL annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
IMPL previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
IMPL next annual earnings announcement has not yet been scheduled

OtherIMPLprofitabilitymetrics:

Annual Revenue

$12.65 M
IMPL annual revenue is $12.65 million

Annual Net Income

-$106.31 M
IMPL annual net profit is -$106.31 million

Annual EBIT

-$83.18 M
IMPL annual earnings before interest & taxes is -$83.18 million

Annual EPS

-$4.53
IMPL annual earnings per share is -$4.53

Quarterly EBITDA

-$12.18 M
+$3.93 M+24.39%

September 1, 2023

Summary

Performance

3-Month Change

+24.39%

1-Year Change

+41.86%

3-Year Change

-40.58%

5-Year Change

-27.01%

IMPL Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$8.66 M

3-Year Low

-$23.94 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2023
IMPL previous earnings announcement was published on Sep 1, 2023

Next Quarterly Earnings Report Date

N/A
IMPL next earnings announcement has not yet been scheduled

OtherIMPLprofitabilitymetrics:

Quarterly Revenue

$5.02 M
IMPL quarterly revenue is $5.02 million

Quarterly Net Income

-$13.81 M
IMPL quarterly net profit is -$13.81 million

Quarterly EBIT

-$12.81 M
IMPL quarterly earnings before interest & taxes is -$12.81 million

Quarterly EPS

-$0.58
IMPL quarterly earnings per share is -$0.58

TTM EBITDA

-$68.90 M
+$8.77 M+11.29%

September 1, 2023

Summary

Performance

3-Month Change

+11.29%

1-Year Change

+21.7%

3-Year Change

-122.61%

5-Year Change

-618.65%

IMPL TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$9.59 M

3-Year Low

-$89.19 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2023
IMPL previous earnings announcement was published on Sep 1, 2023

Next Quarterly Earnings Report Date

N/A
IMPL next earnings announcement has not yet been scheduled

OtherIMPLprofitabilitymetrics:

TTM Revenue

$20.99 M
IMPL TTM revenue is $20.99 million

TTM Net Income

-$74.28 M
IMPL TTM net profit is -$74.28 million

TTM EBIT

-$70.11 M
IMPL TTM earnings before interest & taxes is -$70.11 million

TTM EPS

-$3.13
IMPL TTM earnings per share is -$3.13

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$83.18 M
IMPL annual EBITDA is -$83.18 million

Annual Net Income

-$106.31 M
IMPL annual net profit is -$106.31 million

Annual Interest Expense

-
IMPL annual interest expense value is unknown

Annual Income Tax

$0.00
IMPL annual income tax is $0.00

Annual D&A

$1.20 M
IMPL annual depreciation & amortization is $1.20 million

IMPL EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-18.2%+41.9%+21.7%
3 y3 years-103.7%-40.6%-122.6%
5 y5 years-103.7%-27.0%-618.6%

IMPL EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+18.2%at lowat high+96.6%at high+29.5%
5 y5-year+103.7%at low+40.6%+96.6%+618.7%+29.5%
alltimeall time+103.7%at low+40.6%+96.6%+618.7%+29.5%

Impel Pharmaceuticals EBITDA History

DateAnnualQuarterlyTTM
Sep 2023
-
-$12.18 M(-24.4%)
-$68.90 M(-11.3%)
Jun 2023
-
-$16.10 M(-29.0%)
-$77.67 M(-5.6%)
Mar 2023
-
-$22.68 M(+26.5%)
-$82.25 M(+0.3%)
Dec 2022
-$83.18 M(+18.2%)
-$17.94 M(-14.4%)
-$81.98 M(-6.8%)
Sep 2022
-
-$20.94 M(+1.2%)
-$87.99 M(-1.3%)
Jun 2022
-
-$20.69 M(-7.7%)
-$89.19 M(+7.2%)
Mar 2022
-
-$22.41 M(-6.4%)
-$83.19 M(+18.2%)
Dec 2021
-$70.40 M
-$23.94 M(+8.1%)
-$70.40 M(+17.8%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$22.14 M(+50.7%)
-$59.77 M(+29.1%)
Jun 2021
-
-$14.70 M(+52.8%)
-$46.28 M(+4.5%)
Mar 2021
-
-$9.62 M(-27.7%)
-$44.29 M(+0.1%)
Dec 2020
-$44.26 M(+8.4%)
-$13.31 M(+53.6%)
-$44.26 M(+43.0%)
Sep 2020
-
-$8.66 M(-31.8%)
-$30.95 M(+38.9%)
Jun 2020
-
-$12.70 M(+32.5%)
-$22.29 M(+132.5%)
Mar 2020
-
-$9.59 M
-$9.59 M
Dec 2019
-$40.84 M
-
-

FAQ

  • What is Impel Pharmaceuticals annual EBITDA?
  • What is the all time high annual EBITDA for Impel Pharmaceuticals?
  • What is Impel Pharmaceuticals annual EBITDA year-on-year change?
  • What is Impel Pharmaceuticals quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Impel Pharmaceuticals?
  • What is Impel Pharmaceuticals quarterly EBITDA year-on-year change?
  • What is Impel Pharmaceuticals TTM EBITDA?
  • What is the all time high TTM EBITDA for Impel Pharmaceuticals?
  • What is Impel Pharmaceuticals TTM EBITDA year-on-year change?

What is Impel Pharmaceuticals annual EBITDA?

The current annual EBITDA of IMPL is -$83.18 M

What is the all time high annual EBITDA for Impel Pharmaceuticals?

Impel Pharmaceuticals all-time high annual EBITDA is -$40.84 M

What is Impel Pharmaceuticals annual EBITDA year-on-year change?

Over the past year, IMPL annual EBITDA has changed by -$12.79 M (-18.16%)

What is Impel Pharmaceuticals quarterly EBITDA?

The current quarterly EBITDA of IMPL is -$12.18 M

What is the all time high quarterly EBITDA for Impel Pharmaceuticals?

Impel Pharmaceuticals all-time high quarterly EBITDA is -$8.66 M

What is Impel Pharmaceuticals quarterly EBITDA year-on-year change?

Over the past year, IMPL quarterly EBITDA has changed by +$8.77 M (+41.86%)

What is Impel Pharmaceuticals TTM EBITDA?

The current TTM EBITDA of IMPL is -$68.90 M

What is the all time high TTM EBITDA for Impel Pharmaceuticals?

Impel Pharmaceuticals all-time high TTM EBITDA is -$9.59 M

What is Impel Pharmaceuticals TTM EBITDA year-on-year change?

Over the past year, IMPL TTM EBITDA has changed by +$19.09 M (+21.70%)